The Latest Breaking News from Seagen

Seagen (NASDAQ:SGEN) reported its Q1 earnings results on Thursday, April 28, 2022 at 04:05 PM. Here's what investors need to know about the announcement. Earnings Seagen beat estimated earnings by 26.0%, reporting an EPS of $-0.74 versus an estimate of $-1.0.

Sanofi SA (NASDAQ:SNY) and Seagen Inc (NASDAQ:SGEN) have announced an exclusive collaboration agreement to design, develop, and commercialize antibody-drug conjugates (ADCs) for up to three cancer targets.  The collaboration will utilize Sanofi's proprietary monoclonal antibody (mAb) technology and Seagen's proprietary ADC technology.  ADCs are antibodies engineered to deliver potent anti-cancer drugs to tumor cells expressing…

Seagen (NASDAQ:SGEN) reported its Q4 earnings results on Wednesday, February 9, 2022 at 04:02 PM. Here's what investors need to know about the announcement. Earnings Seagen missed estimated earnings by 15.85%, reporting an EPS of $-0.95 versus an estimate of $-0.82.

If history is any guide, there may be trouble ahead for shares of Seagen (NASDAQ:SGEN). A so-called "death cross" has formed on its chart and, not surprisingly, this could be bearish for the stock.

Within the last quarter, Seagen (NASDAQ: SGEN) has observed the following analyst ratings: Within the last quarter, Seagen (NASDAQ:SGEN) has observed the following analyst ratings: